-
Founded in:
1995-12-14 -
Country:
China -
Address:
No. 28 Gaoxin Avenue, Jiulongpo District, Chongqing -
Tax NO.:
91500000202877396J -
Registered Funds:
38.26 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Magnolia (Wang Chunhua) |
|
0 | ||
| Angelicae Dahuricae Radix |
|
0 | ||
| RADIX SCUTELLARIAE |
|
0 | ||
| Bupleurum |
|
0 | ||
| Riligustilide |
|
89354-45-0 | 0 | |
| Platycodonis Radix |
|
0 | ||
| PEPPERMINT |
|
0 | ||
| Chrysanthemum |
|
0 | ||
| SCHIZONEPETAE SPICA |
|
0 | ||
| Citrus aurantium (fried) |
|
0 | ||
| SAPOSHNIKOVIAE RADIX |
|
0 | ||
| Asari Radix et Rhizoma |
|
0 | ||
| Vitex rotundifolia (fried) |
|
0 | ||
| Borneol |
|
507-70-0 | 1 | |
| water buffalo horn power |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CASSIAE SEMEN |
Clears the liver and improves eyesight, moistens the intestines and promotes bowel movements
More
Clears the liver and improves eyesight, moistens the intestines and promotes bowel movements |
0 | ||
| Artemisiae Scopariae Herba |
Lowers plasma total cholesterol and triglycerides
More
Lowers plasma total cholesterol and triglycerides |
0 | ||
| TAXILLI HERBA |
It can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein. It can clear the liver and improve eyesight, moisten the intestines and promote bowel movements. 1. Reduce plasma total cholesterol and triglycerides. 2. Reduce triglycerides in the liver and inhibit platelet aggregation.
More
It can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein. It can clear the liver and improve eyesight, moisten the intestines and promote bowel movements. 1. Reduce plasma total cholesterol and triglycerides. 2. Reduce triglycerides in the liver and inhibit platelet aggregation. |
0 | ||
| Fleeceflower root HRS |
Lowers liver triglycerides and inhibits platelet aggregation
More
Lowers liver triglycerides and inhibits platelet aggregation |
0 | ||
| Ascorbic Acid |
It can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein. It can clear the liver and improve eyesight, moisten the intestines and promote bowel movements. 1. Reduce plasma total cholesterol and triglycerides. 2. Reduce triglycerides in the liver and inhibit platelet aggregation.
More
It can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein. It can clear the liver and improve eyesight, moisten the intestines and promote bowel movements. 1. Reduce plasma total cholesterol and triglycerides. 2. Reduce triglycerides in the liver and inhibit platelet aggregation. |
50-81-7 | 28 | |
| Nicotinic acid |
Can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein
More
Can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein |
59-67-6 | 15 | |
| Vitamin B series |
It can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein. It can clear the liver and improve eyesight, moisten the intestines and promote bowel movements. 1. Reduce plasma total cholesterol and triglycerides. 2. Reduce triglycerides in the liver and inhibit platelet aggregation.
More
It can significantly reduce the content of triglycerides and cholesterol, increase high-density lipoprotein and reduce low-density lipoprotein. It can clear the liver and improve eyesight, moisten the intestines and promote bowel movements. 1. Reduce plasma total cholesterol and triglycerides. 2. Reduce triglycerides in the liver and inhibit platelet aggregation. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cmnamomi Mmulus |
|
0 | ||
| PAEONIAE RADIX ALBA |
|
0 | ||
| Giner Oil |
|
0 | ||
| Jujubae Fructus |
|
0 | ||
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Red ginseng |
|
0 | ||
| Atractylodis Macrocephalae Rhizoma |
|
0 | ||
| Poria |
|
0 | ||
| DGL |
|
0 | ||
| Bifidobacterium culture fluid |
|
0 | ||
| Tangerine peel syrup |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rifaximin |
This product is a rifamycin derivative and the first non-aminoglycoside intestinal antibiotic. This product has a strong effect and a broad antibacterial spectrum. It has good antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus faecalis among Gram-positive aerobic bacteria, and against Salmonella, Escherichia coli, Shigella and Yersinia enterocolitica among Gram-negative aerobic bacteria. This product has high antibacterial activity against Proteus, Clostridium difficile among Gram-positive anaerobic bacteria, and Bacteroides among Gram-negative anaerobic bacteria. This product is not absorbed and maintains extremely high concentrations in the intestine, while it does not exist in other organs. When using this product, there is no need to use intestinal antispasmodics (such as lopramamide, etc.) or intestinal adsorbents (such as white clay, pectin, etc.). This product acts quickly, and diarrhea will no longer occur after 2 days, and abdominal cramps, headaches, nausea, and vomiting symptoms will disappear quickly. This product is superior to neomycin, streptomycin and other aminoglycoside antibiotics in the following features: ① This product does not damage hearing function; ② It does not cause renal damage; ③ Parasitic normal flora, especially non-pathogenic enteric bacteria Escherichia coli, quickly relocate to the intestines to avoid repeated infection; ④ Intestinal mucosal inflammation may tend to disappear. Mucosal inflammation is a contraindication to the use of topical aminoglycosides, because the inflammation may be aggravated after medication.
More
This product is a rifamycin derivative and the first non-aminoglycoside intestinal antibiotic. This product has a strong effect and a broad antibacterial spectrum. It has good antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus faecalis among Gram-positive aerobic bacteria, and against Salmonella, Escherichia coli, Shigella and Yersinia enterocolitica among Gram-negative aerobic bacteria. This product has high antibacterial activity against Proteus, Clostridium difficile among Gram-positive anaerobic bacteria, and Bacteroides among Gram-negative anaerobic bacteria. This product is not absorbed and maintains extremely high concentrations in the intestine, while it does not exist in other organs. When using this product, there is no need to use intestinal antispasmodics (such as lopramamide, etc.) or intestinal adsorbents (such as white clay, pectin, etc.). This product acts quickly, and diarrhea will no longer occur after 2 days, and abdominal cramps, headaches, nausea, and vomiting symptoms will disappear quickly. This product is superior to neomycin, streptomycin and other aminoglycoside antibiotics in the following features: ① This product does not damage hearing function; ② It does not cause renal damage; ③ Parasitic normal flora, especially non-pathogenic enteric bacteria Escherichia coli, quickly relocate to the intestines to avoid repeated infection; ④ Intestinal mucosal inflammation may tend to disappear. Mucosal inflammation is a contraindication to the use of topical aminoglycosides, because the inflammation may be aggravated after medication. |
80621-81-4 | 36 |